Detalhe da pesquisa
1.
Baseline Stroke Risk and Efficacy of Dual-Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial.
Stroke
; 55(2): 385-391, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174567
2.
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Circulation
; 144(22): 1738-1746, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649459
3.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med
; 380(20): 1906-1917, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091372
4.
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Stroke
; 52(3): 1065-1068, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504190
5.
Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.
Stroke
; 52(7): 2414-2417, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940954
6.
Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial.
Stroke
; 52(12): e773-e776, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634925
7.
Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.
Stroke
; 52(3): 1069-1073, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588594
8.
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
N Engl J Med
; 379(3): 215-225, 2018 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766750
9.
Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
Circulation
; 140(8): 658-664, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31238700
10.
Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
Stroke
; 51(3): 792-799, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078486
11.
Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial.
Stroke
; 51(7): 2058-2065, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32568642
12.
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Stroke
; 51(6): 1758-1765, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404035
13.
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.
Clin Trials
; 17(6): 617-626, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666831
14.
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation.
Eur Heart J Suppl
; 22(Suppl I): I13-I21, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33093818
15.
Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
Stroke
; 50(3): 675-682, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30776996
16.
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
N Engl J Med
; 375(1): 35-43, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160892
17.
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.
Blood
; 129(22): 2980-2987, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356246
18.
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Circulation
; 136(10): 907-916, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28655834
19.
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
Stroke
; 49(7): 1678-1685, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915123
20.
Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Stroke
; 48(1): 167-173, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27899747